Edition:
India

Immune Pharmaceuticals Inc (IMNP.OQ)

IMNP.OQ on NASDAQ Stock Exchange Capital Market

0.20USD
1:30am IST
Change (% chg)

$-0.00 (-1.68%)
Prev Close
$0.20
Open
$0.21
Day's High
$0.22
Day's Low
$0.20
Volume
62,823
Avg. Vol
98,462
52-wk High
$2.73
52-wk Low
$0.17

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.00 -0.146
FY 2017 Dec '17 0.00 -0.695
Sep '17 0.00 -0.534
Jun '17 0.00 -0.500
Mar '17 0.00 -0.427
FY 2016 Dec '16 0.00 -1.538
Sep '16 0.00 -3.139
Jun '16 0.00 -2.659
Mar '16 0.00 -3.486
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-18 1 0.00 0.00 0.00 --
Year Ending Dec-19 1 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Sep-18 1 -0.09 -0.09 -0.09 --
Quarter Ending Dec-18 1 -0.10 -0.10 -0.10 --
Year Ending Dec-18 1 -0.51 -0.51 -0.51 --
Year Ending Dec-19 1 -0.43 -0.43 -0.43 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 30.93 32.76
P/E High - Last 5 Yrs. -- 40.66 45.44
P/E Low - Last 5 Yrs. -- 23.70 24.26
Beta 2.17 0.90 0.89
Price to Sales (TTM) -- 3.94 5.73
Price to Book (MRQ) -- 4.88 5.47
Price to Tangible Book (MRQ) -- 5.70 7.05
Price to Cash Flow (TTM) -- 22.85 23.29
% Owned Institutions 5.00 1.23 2.21

Dividends

  Company industry sector
Dividend Yield -- 1.57 1.51
Dividend Yield - 5 Year Avg -- 1.58 1.52
Dividend 5 Year Growth Rate -- 4.35 5.22
Payout Ratio(TTM) -- 45.85 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 2.28 8.01
Sales (TTM) vs TTM 1 Yr. Ago -- 4.77 5.64
Sales - 5 Yr. Growth Rate -- 9.94 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago 81.21 17.61 20.60
EPS (TTM) vs TTM 1 Yr. Ago 69.50 -- --
EPS - 5 Yr. Growth Rate -- 9.75 10.66
Capital Spending - 5 Yr. Growth Rate -4.18 15.37 15.33

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.15 2.22
Current Ratio (MRQ) 0.02 2.94 3.03
LT Debt to Equity (MRQ) -- 10.03 12.51
Total Debt to Equity (MRQ) -- 14.07 16.84
Interest Coverage (TTM) -7.64 35.78 32.64

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 54.72 54.37
Gross Margin - 5 Yr. Avg. -- 52.10 52.17
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -301,733.31 18.50 10.81
Operating Margin (TTM) -- 14.31 4.57
Operating Margin - 5 Yr. Avg. -343,366.69 14.45 6.23
Pre-Tax Margin (TTM) -- 14.80 5.43
Pre-Tax Margin - 5 Yr. Avg. -459,700.00 14.86 6.67
Net Profit Margin (TTM) -- 11.05 1.72
Net Profit Margin - 5 Yr. Avg. -436,680.91 11.16 2.94
Effective Tax Rate (TTM) -- 23.22 23.11
Effective Tax Rate - 5 Yr. Avg. -- 23.49 23.98

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 953,055,695 860,399,112
Net Income/Employee (TTM) -3,618,000 112,126,539 101,210,045
Receivable Turnover (TTM) -- 5.72 5.87
Inventory Turnover (TTM) -- 2.63 3.41
Asset Turnover (TTM) 0.00 0.96 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -120.00 11.58 11.14
Return on Assets - 5 Yr. Avg. -74.56 12.95 12.40
Return on Investment (TTM) -201.88 15.07 14.61
Return on Investment - 5 Yr. Avg. -109.15 16.90 16.14
Return on Equity (TTM) -1,487.29 16.60 16.34
Return on Equity - 5 Yr. Avg. -477.80 17.97 17.40
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 46.87 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Immune Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 1.75%
# of Holders: 18
Total Shares Held: 561,311
3 Mo. Net Change: 0
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 0
# Reduced Positions: 0
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.